| Symbol | FNCH |
|---|---|
| Name | FINCH THERAPEUTICS GROUP, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 02109 United States MA 75 State Street Suite100 |
| Telephone | +1 2032731698 |
| Fax | — |
| — | |
| Website | https://www.finchtherapeutics.com/ |
| Incorporation | US |
| Incorporated On | 2017 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | Danforth Advisors LLC; |
| Audit Status | AUDITED |
| Reporting Status | Alternative Reporting Standard |
| CIK | 0001733257 |
| Description | Finch Therapeutics is a microbiome technology company with a portfolio of intellectual property and microbiome assets. Finchs objectives are to realize the value of its intellectual property estate through licensing its technology to collaboration partners and enforcing its patent rights against infringing parties through intellectual property litigation and, in certain cases, to generate additional data on selected product candidates through academic collaborations. Additional info from OTC: |
New Form EFFECT - Finch Therapeutics Group, Inc. Filed: 2024-11-04 AccNo: 9999999995-24-003352 Size: 1 KB
Read moreNew Form POS AM - Finch Therapeutics Group, Inc. Filed: 2024-11-01 AccNo: 0001193125-24-249236 Size: 19 KB
Read moreNew Form S-8 POS - Finch Therapeutics Group, Inc. Filed: 2024-11-01 AccNo: 0001193125-24-249234 Size: 20 KB
Read moreNew Form S-8 POS - Finch Therapeutics Group, Inc. Filed: 2024-11-01 AccNo: 0001193125-24-249233 Size: 20 KB
Read moreNew Form 25 - Finch Therapeutics Group, Inc. Filed: 2024-10-31 AccNo: 0001193125-24-248169 Size: 15 KB
Read more(35% Negative) Finch Therapeutics Group, Inc. (FNCH) Announces Business Combination
Read moreSera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference
Read more